Annual report [Section 13 and 15(d), not S-K Item 405]

Balance Sheets

v3.26.1
Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash $ 6,178,021 $ 4,091,990
Total current assets 6,178,021 4,091,990
Acquired patents, net 1,779
Total assets 6,178,021 4,093,769
Current liabilities    
Accounts payable & accrued interest 4,874,489 2,802,946
Deferred compensation 673,819 306,281
Unreimbursed expenses 276,496 75,916
Total current liabilities 5,824,804 3,185,143
Total liabilities 5,824,804 3,185,143
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 14,298,446 and 13,152,729 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively 14,299 13,153
Additional paid-in capital 87,475,924 68,674,261
Accumulated deficit (87,137,006) (67,778,788)
Total stockholders’ equity 353,217 908,626
Total liabilities and stockholders’ equity $ 6,178,021 $ 4,093,769